Air Street Press

Nathan Benaich (Air Street Capital)
undefined
Nov 20, 2025 • 5min

Profluent raises $106M from Jeff Bezos

Profluent builds frontier AI systems to unlock programmable biology. Now, Profluent has raised $106M led by Bezos Expeditions and Altimeter, with continued support from Spark, Insight, and Air Street. The company is now the largest position in Air Street’s second fund. This new capital accelerates the company’s path toward scaling frontier protein models and, ultimately, delivering the first AI-designed therapeutic to a human patient.
undefined
Nov 18, 2025 • 7min

Introducing Profluent’s E1: Retrieval-augmentation for protein engineering

Understanding how protein sequence encodes structure and function remains one of the central challenges in the life sciences. Yet most protein language models still treat each sequence as an isolated datapoint. This forces the entire burden of evolutionary context into model parameters, which leads to blind spots in underrepresented families and amplifies the biases of sequence databases. Profluent’s new E1 family demonstrates that this constraint is no longer necessary. Retrieval augmentation, a technique that transformed natural language processing, is now beginning to reshape protein modeling by allowing models to incorporate evolutionary information at the moment of inference rather than storing it all in weights.
undefined
Nov 17, 2025 • 8min

Poolside acquires Fern Labs

Poolside is building one of the strongest full-stack AI companies in the world: energy, compute, models, and the infrastructure needed to run multi-agent systems for complex enterprise workflows. The Fern team brings a deeply opinionated agentic core - built from first principles and stress-tested on real workloads - into a company with scale, distribution, and compute firepower. Fern’s architecture was built for agent specialization and coordinated long-horizon work - the exact capabilities poolside can scale into a full production environment.
undefined
Nov 9, 2025 • 34min

State of AI: November 2025 newsletter

Welcome to the latest issue of the State of AI, an editorialized newsletter formerly known as Guide to AI that covers the key developments in AI policy, research, industry, and start-ups over the last month. First up, a few reminders:Read more on press.airstreet.com
undefined
Nov 4, 2025 • 3min

PARIMA’s first regulatory approval and another wake-up call for Europe

PARIMA, a global leader in cultivated proteins, has become the first European company to secure regulatory approval for cultivated meat, with the Singapore Food Agency granting clearance for its cultivated chicken. It’s a historic moment for Europe’s food-tech sector, but one that’s unfolding thousands of miles away from home.
undefined
Oct 29, 2025 • 4min

Gourmey acquires Vital Meat and forms PARIMA to industrialize of cultivated food

Building a next-generation food company.
undefined
Oct 27, 2025 • 4min

Poolside launches Project Horizon: 2GW of AI compute

Integrating across compute, power, and intelligence.
undefined
Oct 9, 2025 • 7min

The State of AI Report 2025

The State of AI Report is the most widely read and trusted analysis of key developments in AI. Published annually since 2018, the open-access report aims to spark informed conversation about the state of AI and what it means for the future. Produced by AI investor Nathan Benaich and Air Street Capital. State of AI Report 2025 is reviewed by leading AI practioners in industry and research.
undefined
Sep 19, 2025 • 2min

Air Street Capital partners with NVIDIA on a £2B investment to accelerate the UK AI ecosystem

AI is the ultimate force multiplier on technological progress in our digital, data-driven world. Our mission at Air Street Capital has always been to back the most ambitious teams building breakthrough AI products that would have seemed like magic when I started investing over a decade ago. Key to these inflection points is the infrastructure that enables them: NVIDIA computing systems. I have long argued that NVIDIA is the defining company of the AI era, powering breakthroughs in science, industry, and national strategy. This is why I’m excited to share that we are deepening that story together: Air Street Capital is partnering with NVIDIA as part of its new £2B commitment to the UK AI ecosystem.
undefined
Aug 26, 2025 • 4min

Our investment in Delfa to fix clinical trials

Clinical trials are the bottleneck of the pharmaceutical industry. They’re slow, expensive, and often fail, not only because the science frequently doesn’t pan out, but because the ops don’t either. That’s why we’re leading the $3.8M Seed round for Delfa. The team is building an AI-native operating system for clinical trials, starting with patient enrolment, the most broken part of the process.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app